Breaking News, Collaborations & Alliances

Quotient Sciences, CytoAgents Form COVID-19 Collaboration

Expedites human clinical trials for COVID-19 drug candidate

By: Contract Pharma

Contract Pharma Staff

A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was formed by Quotient Sciences, a provider of drug development and manufacturing solutions, and CytoAgents, a privately held biotech focused on the development of pharmaceutical products for the treatment of viral infectious diseases. The partnership will focus on utilizing Quotient’s integrated service portfolio to support the rapid development of CytoAgents’ lead COVID-19 drug candidate,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters